| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $174.6M | — | -18.4% |
| R&D Expense | $8.2M | — | -11.3% |
| SG&A Expense | $86.9M | — | +1.2% |
| Operating Income | -$1.06B | — | -96.2% |
| Pre-tax Income | -$1.29B | — | -98.2% |
| Income Tax | -$30.9M | — | +74.0% |
| Net Income | -$1.26B | — | -136.7% |
| EPS (Basic) | -$3.31 | — | -113.5% |
| EPS (Diluted) | -$3.31 | — | -113.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $513.7M | -6.1% | +161.8% |
| Current Assets | $611.1M | -8.0% | +109.4% |
| Total Assets | $4.95B | -32.1% | -23.2% |
| Current Liabilities | $331.5M | -36.5% | -10.0% |
| Long-term Debt | $2.42B | -32.9% | +5.1% |
| Stockholders' Equity | $2.23B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$247.5M | — | -14.9% |
| Capital Expenditures | $79.5M | — | +104.7% |
| Investing Cash Flow | $1.19B | — | +667.2% |
| Financing Cash Flow | -$1.11B | — | -582.3% |
| Free Cash Flow | -$327.0M | — | -28.6% |
| -40.1% |